Immunisation against infectious disease / Joint Committee on Vaccination and Immunisation.

  • Great Britain. Joint Committee on Vaccination and Immunisation.
Date:
1988
Catalogue details

Licence: Open Government Licence

Credit: Immunisation against infectious disease / Joint Committee on Vaccination and Immunisation. Source: Wellcome Collection.

    36/132 (page 26)
    immunogen is prepared by treating a cell-free preparation of toxin with formaldehyde and thereby converting it into the innocuous tetanus toxoid. The vaccines available for immunisation are: Diphtheria/tetanus Diphtheria/tetanus Diphtheria/tetanus/pertussis Diphtheria/tetanus/pertussis Vaccines should be stored at 2—8°C. The dose is 0.5ml given by intramuscular or deep subcutaneous injection. 5.3 Recommendations 5.3.1 For immunisation of infants and children under 10 years. a. Primary immunisation. Triple vaccine, that is, vaccine containing diphtheria toxoid, tetanus toxoid, and Bordetella pertussis, is recommended for infants from 3 months of age. Either adsorbed or plain vaccine may be used but adsorbed is preferable as it has been shown to cause fewer reactions. If the pertussis component is contraindicated adsorbed diphtheria/ tetanus vaccine should be used. A course of primary immunisation consists of 3 doses with an interval of 6-8 weeks between the first and second doses and 4—6 months between the second and third doses. Ifa course is interrupted it may be resumed; there is no need to start again. The dose is 0.5ml given by intramuscular or deep subcutaneous injection. b. Reinforcing doses in children Diphtheria/tetanus vaccine is recommended immediately prior to school entry, preferably with an interval of at least 3 years from the last dose of the primary course. A further reinforcing dose of tetanus vaccine alone is recommended for those aged 15—19 years or before leaving school. 5.3.2 For immunisation of adults and children over 10 years. a. For primary immunisation the course consists of 3 doses of 0.5ml by intramuscular or deep subcutaneous injection, with intervals of 6-8